Innocoll plans to price $50 million public offering of ordinary stock

Shareholders to sell further $15 million plus $9.75 million greenshoe

By Devika Patel

Knoxville, Tenn., June 13 – Innocoll Holdings plc said it will price a $50 million public sale of ordinary shares and a $15 million secondary sale of shares with a $9.75 million secondary greenshoe.

Morgan Stanley is the lead bookrunning manager and Piper Jaffray & Co. is the joint bookrunning manager.

The specialty pharmaceutical and medical device company is based in Athlone, Ireland.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.